Lupin Limited has informed the Exchange regarding a press release dated August 14, 2020, titled "Lupin Presents Phase 3 Data for Solosec�� (secnidazole) Demonstrating SignificantResponse Rate in Female Patients with Trichomoniasis".
Lupin Limited has informed the Exchange regarding a press release dated August 14, 2020, titled "Lupin Presents Phase 3 Data for Solosec�� (secnidazole) Demonstrating SignificantResponse Rate in Female Patients with Trichomoniasis".